Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

55.44 -1.32 (-2.33%)

Streaming Delayed Price Updated: 3:30 PM EDT, Apr 16, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,202,346
Open	56.84
Bid (Size)	55.38 (1,100)
Ask (Size)	55.47 (100)
Prev. Close	56.76
Today's Range	54.57 - 57.24
52wk Range	33.03 - 78.48
Shares Outstanding	78,935,098
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Billion Reasons to Love CRISPR Therapeutics Right Now ↗

April 13, 2026

The company's strong cash position gives investors confidence in the gene-editing stock.

Via The Motley Fool

This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area ↗

April 08, 2026

Innovation often pays off, and this biotech could cement its innovative capabilities in the next few years.

Via The Motley Fool

Performance

YTD	+3.1%	+3.1%
1 Month	+14.5%	+14.5%
3 Month	-2.5%	-2.5%
6 Month	-22.8%	-22.8%
1 Year	+42.3%	+42.3%

More News

Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position? ↗

April 07, 2026

Via The Motley Fool

CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? ↗

March 23, 2026

Via The Motley Fool

Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026

March 20, 2026

Via Finterra

Is CRISPR Therapeutics Stock a Buy Now? ↗

March 20, 2026

Via The Motley Fool

3 Monster Stocks to Hold for the Next 10 Years ↗

March 10, 2026

Via The Motley Fool

This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday ↗

March 10, 2026

Via The Motley Fool

Why Is CRSP Stock Falling Pre-Market Today? ↗

March 10, 2026

Via Stocktwits

RIVN Stock Gains 4% Pre-Market After TD Cowen Upgrade: Analyst Sees Strong Demand For Upcoming R2 Models ↗

March 10, 2026

Via Stocktwits

Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of ↗

March 04, 2026

Via The Motley Fool

Is CRISPR Therapeutics Stock Too Risky to Buy Right Now? ↗

March 02, 2026

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

March 01, 2026

Via The Motley Fool

Is CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off? ↗

February 20, 2026

Via The Motley Fool

The Gene‑Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices ↗

February 20, 2026

Via The Motley Fool

2 Innovative Biotech Stocks That May Climb 58% and 200%, According to Wall Street ↗

February 19, 2026

Via The Motley Fool

CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows ↗

February 19, 2026

Via MarketBeat

Should You Buy Shares of CRISPR Therapeutics in February? ↗

February 18, 2026

Via The Motley Fool

The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026 ↗

February 13, 2026

Via The Motley Fool

Why CRISPR Therapeutics Stock Is Up Today (Despite Its Q4 Earnings Miss) ↗

February 13, 2026

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

January 30, 2026

Via The Motley Fool

Forget AI Stocks: This Biotech Could Cure What AI Can't Touch ↗

January 29, 2026

Via The Motley Fool

Nasdaq, S&P 500 Futures Climb Ahead Of Apple Earnings: Why META, TSLA, MP, CRML, SER Are On Traders' Radar Today ↗

January 29, 2026

Via Stocktwits

Cathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops ↗

January 27, 2026

Via Benzinga

2 Biotech Stocks That Could Soar This Year ↗

January 12, 2026

Via The Motley Fool

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?

Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.

What exchange does CRISPR Therapeutics AG - Common Shares trade on?

CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?

The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market

What is the current price of CRISPR Therapeutics AG - Common Shares?

The current price of CRISPR Therapeutics AG - Common Shares is 55.44

When was CRISPR Therapeutics AG - Common Shares last traded?

The last trade of CRISPR Therapeutics AG - Common Shares was at 04/16/26 03:30 PM ET

What is the market capitalization of CRISPR Therapeutics AG - Common Shares?

The market capitalization of CRISPR Therapeutics AG - Common Shares is 4.38B

How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?

CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.